APGE
Apogee Therapeutics

415
Mkt Cap
$4.59B
Volume
2.85M
52W High
$84.56
52W Low
$26.20
PE Ratio
-15.67
APGE Fundamentals
Price
$66.04
Prev Close
$68.50
Open
$68.06
50D MA
$71.39
Beta
0.00
Avg. Volume
830,659.22
EPS (Annual)
-$4.22
P/B
5.00
Rev/Employee
$0.00
$3,859.60
Loading...
Loading...

About

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), ashma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
261

Frequently Asked Questions

What is Market Cap of Apogee Therapeutics Inc.?
What is the 52-week high for Apogee Therapeutics Inc.?
What is the 52-week low for Apogee Therapeutics Inc.?
What is Apogee Therapeutics Inc. stock price today?
What was Apogee Therapeutics Inc. stock price yesterday?
What is the PE ratio of Apogee Therapeutics Inc.?
What is the Price-to-Book ratio of Apogee Therapeutics Inc.?
What is the 50-day moving average of Apogee Therapeutics Inc.?
How many employees does Apogee Therapeutics Inc. have?

Latest APGE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.